Published in J Clin Microbiol on April 01, 2005
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol (2008) 1.11
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J Clin Microbiol (2009) 1.07
Prevention of assay interference in infectious-disease serology tests done on the liaison platform. Clin Vaccine Immunol (2008) 1.06
Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis (2006) 1.03
Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system. Clin Vaccine Immunol (2008) 1.01
Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol (2012) 0.98
Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol (2009) 0.96
Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol (2009) 0.92
Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin Vaccine Immunol (2007) 0.91
Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States. J Clin Microbiol (2015) 0.90
Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clin Vaccine Immunol (2013) 0.87
Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods. Parasitol Res (2012) 0.85
Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy. Clin Vaccine Immunol (2010) 0.84
Antiparasitic treatment suppresses production and avidity of Toxoplasma gondii-specific antibodies in a murine model of acute infection*. Eur J Microbiol Immunol (Bp) (2011) 0.84
Toxoplasmosis and pregnancy. Can Fam Physician (2014) 0.84
Multiplexed Anti-Toxoplasma IgG, IgM, and IgA Assay on Plasmonic Gold Chips: towards Making Mass Screening Possible with Dye Test Precision. J Clin Microbiol (2016) 0.82
Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre- and post-transplantation status. Ann Trop Med Parasitol (2011) 0.80
The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection. Microbes Infect (2012) 0.80
Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling. Parasitology (2015) 0.78
Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway. PLoS One (2015) 0.78
Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants. Med Microbiol Immunol (2009) 0.77
Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J Clin Microbiol (2008) 0.77
Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol (2012) 0.77
IgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India. Korean J Parasitol (2014) 0.75
Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii. Eur J Microbiol Immunol (Bp) (2015) 0.75
Prenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy. Medicine (Baltimore) (2016) 0.75
Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis. J Clin Microbiol (2016) 0.75
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol (1997) 2.22
Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol (1990) 2.19
Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis (1998) 1.78
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin Microbiol Infect (1996) 1.46
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol (2002) 1.45
The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect (1994) 1.40
Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol (2001) 1.33
Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting. Clin Diagn Lab Immunol (2000) 1.31
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
[Value of the study of IgG avidity for the diagnosis of toxoplasmosis]. Pathol Biol (Paris) (1993) 1.26
Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol (2003) 1.22
Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect (2004) 1.20
A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol (1999) 1.17
Comparison of two commercially available avidity tests for toxoplasma-specific IgG antibodies. Arch Med Res (2002) 1.15
Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems. Clin Diagn Lab Immunol (2001) 1.09
Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol (1998) 1.08
A simple, rapid enzyme-linked immunosorbent assay for evaluating immunoglobin G antibody avidity in toxoplasmosis. Diagn Microbiol Infect Dis (1998) 1.08
Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol Infect (1991) 1.01
IgG recognizing 21-24 kDa and 30-33 kDa tachyzoite antigens show maximum avidity maturation during natural and accidental human toxoplasmosis. Rev Inst Med Trop Sao Paulo (2000) 0.91
Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin Diagn Lab Immunol (2001) 0.85
Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol (2006) 3.24
Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis (2002) 2.78
Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ (2004) 2.57
Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis (2009) 2.33
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med (2009) 2.28
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr (2008) 1.90
Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol (2004) 1.86
Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis (2008) 1.85
Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol (2002) 1.75
Immunology of Toxoplasma gondii. Immunol Rev (2011) 1.66
Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol (2009) 1.63
Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J Clin Microbiol (2011) 1.62
Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis (2009) 1.47
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol (2002) 1.45
Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int (2011) 1.38
Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis (2006) 1.35
Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis (2006) 1.35
Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol (2008) 1.32
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32
Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol (2004) 1.28
Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol (2010) 1.26
Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur J Immunol (2004) 1.19
Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2012) 1.19
Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis (2007) 1.18
High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status. Parasit Vectors (2012) 1.17
The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J Infect Dis (2002) 1.16
Comparison of two commercially available avidity tests for toxoplasma-specific IgG antibodies. Arch Med Res (2002) 1.15
Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population. Parasit Vectors (2011) 1.12
Toxoplasma gondii infection in workers occupationally exposed to unwashed raw fruits and vegetables: a case control seroprevalence study. Parasit Vectors (2011) 1.11
Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect (2006) 1.09
Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J (2008) 1.09
Seroepidemiology of Toxoplasma gondii infection in elderly people in a northern Mexican city. Vector Borne Zoonotic Dis (2012) 1.05
Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol (2014) 1.05
Seroepidemiology of Toxoplasma gondii infection in Tepehuanos in Durango, Mexico. Vector Borne Zoonotic Dis (2012) 1.04
ICOS+ Th cells produce distinct cytokines in different mucosal immune responses. Eur J Immunol (2003) 1.03
Seroepidemiology of infection with Toxoplasma gondii in migrant agricultural workers living in poverty in Durango, Mexico. Parasit Vectors (2013) 1.03
New Vidas assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera. Diagn Microbiol Infect Dis (2006) 1.03
Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg (2010) 1.02
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother (2004) 1.01
Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study. Acta Obstet Gynecol Scand (2010) 1.01
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol (2003) 0.99
Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol (2012) 0.99
Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis (2012) 0.99
Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol (2010) 0.98
A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassay. BMC Dermatol (2009) 0.98
Spatial distribution of soil contamination by Toxoplasma gondii in relation to cat defecation behaviour in an urban area. Int J Parasitol (2008) 0.98
Expression of selectin ligands on murine effector and IL-10-producing CD4+ T cells from non-infected and infected tissues. Eur J Immunol (2004) 0.97
Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol (2010) 0.97
IFN consensus sequence binding protein (Icsbp) is critical for eosinophil development. J Immunol (2008) 0.96
Development of a sensitive method for Toxoplasma gondii oocyst extraction in soil. Vet Parasitol (2011) 0.96
Waterborne toxoplasmosis, northeastern Brazil. Emerg Infect Dis (2007) 0.96
Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). Int J Parasitol (2006) 0.95
Immunoblotting with human native antigen shows stage-related sensitivity in the serodiagnosis of hepatic cystic echinococcosis. Am J Trop Med Hyg (2013) 0.92
Prevalence of Pseudomonas aeruginosa in households of patients with cystic fibrosis. Int J Hyg Environ Health (2004) 0.92
Toxoplasma serotype is associated with development of ocular toxoplasmosis. J Infect Dis (2013) 0.92
TCR V beta 8+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. J Immunol (2003) 0.92
Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients. J Nerv Ment Dis (2013) 0.91
Seroprevalence of Toxoplasma gondii infection and associated risk factors in Huicholes in Mexico. Parasit Vectors (2014) 0.91
Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil. V. Cytokine concentrations in experimentally infected Wistar rats. Parasitol Res (2004) 0.91
Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol (2011) 0.90
Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the literature. Mem Inst Oswaldo Cruz (2009) 0.90
Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clin Lab (2003) 0.90
Schizophrenia and serological methods for diagnosis of toxoplasmosis. Clin Infect Dis (2002) 0.89
Swabs (dry or collected in universal transport medium) and semen can be used for the detection of Chlamydia trachomatis using the cobas 4800 system. J Med Microbiol (2012) 0.89
Modified real-time PCR for detecting, differentiating, and quantifying Ureaplasma urealyticum and Ureaplasma parvum. J Mol Diagn (2011) 0.89
Molecular evidence of the camel strain (G6 genotype) of Echinococcus granulosus in humans from Turkana, Kenya. Trans R Soc Trop Med Hyg (2009) 0.88
Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test. Sex Transm Dis (2013) 0.88
Comparison of CD8+ T Cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis (2007) 0.87
Seroprevalence of Toxoplasma gondii in the Eurasian otter (Lutra lutra) in England and Wales. Parasit Vectors (2013) 0.86
Prevention of toxoplasmosis during pregnancy--an epidemiologic survey over 22 consecutive years. J Perinat Med (2004) 0.86
Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred. Pediatrics (2008) 0.86
In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii. Antimicrob Agents Chemother (2009) 0.85
Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites. Arzneimittelforschung (2004) 0.84
Evaluation of tRNA gene PCR for identification of mollicutes. J Clin Microbiol (2005) 0.84
Microenvironment-dependent requirement of STAT4 for the induction of P-selectin ligands and effector cytokines on CD4+ T cells in healthy and parasite-infected mice. J Immunol (2006) 0.83
The sero-prevalence of Toxoplasma gondii in British marine mammals. Mem Inst Oswaldo Cruz (2009) 0.83
Early and accurate diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J (2008) 0.83
Differential effects of ethanol on IFN-gamma- and TNF-alpha-producing splenic T lymphocytes in a murine model of gram-negative pneumonia. Addict Biol (2007) 0.83
Lack of association between Toxoplasma gondii infection and hypertensive disorders in pregnancy: a case-control study in a Northern Mexican population. Parasit Vectors (2014) 0.82
Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: III. Cytokine levels in peripheral blood of infected humans. Parasitol Res (2003) 0.82
Toxoplasma gondii and the blood-brain barrier. Virulence (2012) 0.82
Investigation of Neospora sp. antibodies in aborted mares from Normandy, France. Vet Parasitol (2003) 0.81
Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants. New Microbiol (2007) 0.79
Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in Western Turkey. Liver Transpl (2008) 0.79
Anemia, leukocytosis and eosinophilia in a resource-poor population with helmintho-ectoparasitic coinfection. J Infect Dev Ctries (2011) 0.79
Perceived social restriction in leprosy-affected inhabitants of a former leprosy colony in northeast Brazil. Lepr Rev (2010) 0.79
Efficacy of chemical and botanical over-the-counter pediculicides available in Brazil, and off-label treatments, against head lice ex vivo. Int J Dermatol (2010) 0.79
Lack of association between Toxoplasma gondii infection and occupational exposure to animals. Eur J Microbiol Immunol (Bp) (2014) 0.79
The United Kingdom National External Quality Assessment Service for parasitology: toxoplasma serology scheme. J Clin Pathol (2010) 0.79
Prevalence of infection with Toxoplasma gondii in landrace and mixed breed pigs slaughtered in Baja California Sur State, Mexico. Eur J Microbiol Immunol (Bp) (2015) 0.78
Alpha CD 2 mAb treatment safely attenuates adoptive transfer colitis. Lab Invest (2005) 0.78
Serum cytokine profile by ELISA in patients with echinococcal cysts of the liver: a stage-specific approach to assess their biological activity. Clin Dev Immunol (2012) 0.78
CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection. World J Gastroenterol (2007) 0.78
CD8+ cells protect mice against reinfection with the intestinal parasite Eimeria falciformis. Microbes Infect (2009) 0.78
Comparison of two methods for serotyping Ureaplasma urealyticum clinical isolates. J Microbiol Methods (2002) 0.78
A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo. J Antimicrob Chemother (2008) 0.78
The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice. Parasitol Res (2007) 0.78
Regulation and migratory role of P-selectin ligands during intestinal inflammation. PLoS One (2013) 0.77